Brought to you by 
Cell Medica allies with the Center for Cell and Gene Therapy
04 Apr 2011
Executive Summary
Cell Medica (developing cell therapies for cancer and infectious diseases) and the Center for Cell and Gene Therapy (CCGT) seek to co-develop cellular therapeutics aimed at treating infections in immunosuppressed patients who have received bone marrow transplants. The parties will also explore the possibility of developing T-cell immunotherapies for hematological malignancies that result from oncogenic viruses.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cell Medica allies with the Center for Cell and Gene Therapy
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice